"We believe we are building the next generation healthcare platform, a platform that leverages personalization and technology unlike any traditional healthcare system, delivering access to affordable, on-demand, high-quality and precision-tailored care to millions of people, the future model of health and wellness that centers around the consumer and the consumer alone," CEO Andrew Dudum said on the call Monday
The faster onset with Retatrutide does come with some considerations
GLP-1 microdosing aligns with this philosophy by: Shifting from Reactive to Proactive Care Instead of waiting for full-blown diabetes or obesity to develop, microdosing allows us to intervene upstream, potentially preventing disease progression before it fully takes hold
Semaglutide: Single-Receptor Action Semaglutide is a GLP-1 receptor agonist
The alpha cells in the pancreas secrete proglucagon when blood glucose levels are low
High-sugar foods waste precious caloric budget on empty nutrition